Introduction: Enterobacter cloacae strains have been isolated from Eastern Cape hospitalised patients. Methodology: We have molecularly characterised blaOXA-48-, blaIMP- and blaVIM-expressing E. cloacae isolates demonstrating resistance to carbapenems from five hospitals by multilocus sequence typing. Organism identification and antimicrobial susceptibility testing was done using automated systems and the isolates were screened for carbapenemases using either conventional or real-time PCR and then typed using multilocus sequence typing. Further characterisation of IMP-type-producing E. cloacae isolates, an unusual occurrence in South Africa, was performed by pulsed-field gel electrophoresis. Results and Conclusion: Twenty-five E. cloacae isolates from 24 patients were investigated. Eighteen (72%) isolates harboured either one of the following genes: blaIMP, blaVIM or blaOXA-48. Multilocus sequence typing data and pulsed-field gel electrophoresis showed that several strains from the same geographical region and hospitals were genetically related.
References
[1]
Yong, D., et al. (2009) Characterization of a New Metallo-Beta-Lactamase Gene, bla(NDM-1), and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India. Antimicrobial Agents and Chemotherapy, 53, 5046-5054. http://dx.doi.org/10.1128/AAC.00774-09
[2]
Ren, Y., et al. (2010) Complete Genome Sequence of Enterobacter cloacae Subsp. Cloacae Type Strain ATCC 13047. Journal of Bacteriology, 192, 2463-2464. http://dx.doi.org/10.1128/JB.00067-10
[3]
Mezzatesta, M.L., Gona, F. and Stefani, S. (2012) Enterobacter cloacae Complex: Clinical Impact and Emerging Antibiotic Resistance. Future Microbiology, 7, 887-902. http://dx.doi.org/10.2217/fmb.12.61
[4]
Bush, K. (2010) Alarming Beta-Lactamase-Mediated Resistance in Multidrug-Resistant Enterobacteriaceae. Current Opinion in Microbiology, 13, 558-564. http://dx.doi.org/10.1016/j.mib.2010.09.006
[5]
Heller, I., Grif, K. and Orth, D. (2012) Emergence of VIM-1-Carbapenemase-Producing Enterobacter cloacae in Tyrol, Austria. Journal of Medical Microbiology, 61, 567-571. http://dx.doi.org/10.1099/jmm.0.038646-0
[6]
Osano, E., et al. (1994) Molecular Characterization of an Enterobacterial Metallo Beta-Lactamase Found in a Clinical Isolate of Serratia marcescens That Shows Imipenem Resistance. Antimicrobial Agents and Chemotherapy, 38, 71-78. http://dx.doi.org/10.1128/AAC.38.1.71
[7]
Gibb, A.P., et al. (2002) Nosocomial Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa with a New bla(IMP) Allele, bla(IMP-7). Antimicrobial Agents and Chemotherapy, 46, 255-258. http://dx.doi.org/10.1128/AAC.46.1.255-258.2002
[8]
Hayakawa, K., et al. (2014) Molecular and Epidemiological Characterization of IMP-Type Metallo-Beta-Lactamase-Producing Enterobacter cloacae in a Large Tertiary Care Hospital in Japan. Antimicrobial Agents and Chemotherapy, 58, 3441-3450. http://dx.doi.org/10.1128/AAC.02652-13
[9]
Ho, S.E., et al. (2002) Carbapenem-Resistant Pseudomonas aeruginosa in Malaysia Producing IMP-7 Beta-Lactamase. Antimicrobial Agents and Chemotherapy, 46, 3286-3287. http://dx.doi.org/10.1128/AAC.46.10.3286-3287.2002
[10]
Hrabák, J. and Cervená, D. (2011) Regional Spread of Pseudomonas aeruginosa ST357 Producing IMP-7 Metallo-β-Lactamase in Central Europe. Journal of Clinical Microbiology, 49, 474-475. http://dx.doi.org/10.1128/JCM.00684-10
[11]
Leung, G.H., Gray, T.J., Cheong, E.Y., Haertsch, P. and Gottlieb, T. (2013) Persistence of Related bla-IMP-4 Metallo-Betalactamase Producing Enterobacteriaceae from Clinical and Environmental Specimens within a Burns Unit in Australia—A Six-Year Retrospective Study. Antimicrobial Resistance and Infection Control, 2, 35.
[12]
Naas, T., Cuzon, G., Bogaerts, P., Glupczynski, Y. and Nordmann, P. (2011) Evaluation of a DNA Microarray (Check-MDR CT102) for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum Beta-Lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 Carbapenemases. Journal of Clinical Microbiology, 49, 1608-1613. http://dx.doi.org/10.1128/JCM.02607-10
[13]
Lauretti, L., Riccio, M.L., Mazzariol, A., Cornaglia, G., Amicosante, G., Fontana, R. and Rossolini, G.M. (1999) Cloning and Characterization of blaVIM, a New Integron-Borne Metallo-Beta-Lactamase Gene from a Pseudomonas aeruginosa Clinical Isolate. Antimicrobial Agents and Chemotherapy, 43, 1584-1590.
[14]
Cardoso, O., Leitão, R., Figueiredo, A., Sousa, J.C., Duarte, A. and Peixe, L.V. (2002) Metallo-Beta-Lactamase VIM-2 in Clinical Isolates of Pseudomonas aeruginosa from Portugal. Microbial Drug Resistance, 8, 93-97. http://dx.doi.org/10.1089/107662902760190635
[15]
Lee, K., Lim, J.B., Yum, J.H., Yong, D., Chong, Y., Kim, J.M. and Livermore, D.M. (2002) blaVIM-2 Cassette-Containing Novel Integrons in Metallo-Beta-Lactamase-Producing Pseudomonas aeruginosa and Pseudomonas putida Isolates Disseminated in a Korean Hospital. Antimicrobial Agents and Chemotherapy, 46, 1053-1058. http://dx.doi.org/10.1128/AAC.46.4.1053-1058.2002
[16]
Pournaras, S., Tsakris, A., Maniati, M., Tzouvelekis, L.S. and Maniatis, A.N. (2002) Novel Variant (blaVIM-4) of the Metallo-Beta-Lactamase Gene blaVIM-1 in a Clinical Strain of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 46, 4026-4028. http://dx.doi.org/10.1128/AAC.46.12.4026-4028.2002
[17]
Toleman, M.A., Rolston, K., Jones, R.N. and Walsh, T.R. (2002) Molecular Characterization of VIM-4, a Novel Metallo-Beta-Lactamaseisolated from Texas: Report from the Cancer Surveillance Program (2001). 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, 27-30 September 2002.
[18]
Yan, J.-J., Hsueh, P.-R., Ko, W.-C., Luh, K.-T., Tsai, S.-H., Wu, H.-M. and Wu, J.-J. (2001) Metallo-Beta-Lactamases in Clinical Pseudomonas Isolates in Taiwan and Identification of VIM-3, a Novel Variant of the VIM-2 Enzyme. Antimicrobial Agents and Chemotherapy, 45, 2224-2228. http://dx.doi.org/10.1128/AAC.45.8.2224-2228.2001
[19]
Poirel, L., Naas, T., Nicolas, D., Collet, L., Bellais, S., Cavallo, J.-D. and Nordmann, P. (2000) Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-Beta-Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in France. Antimicrobial Agents and Chemotherapy, 44, 891-897. http://dx.doi.org/10.1128/AAC.44.4.891-897.2000
[20]
Richet, H.M., Mohammed, J., McDonald, L.C. and Jarvis, W.R. (2001) Building Communication Networks: International Network for the Study and Prevention of Emerging Antimicrobial Resistance. Emerging Infectious Diseases, 7, 319-322. http://dx.doi.org/10.3201/eid0702.010235
[21]
Brink, A.J., Coetzee, J., Clay, C.G., Sithole, S., Richards, G.A., Poirel, L. and Nordmann, P. (2011) Emergence of New Delhi Metallo-Beta-Lactamase (NDM-1) and Klebsiella pneumoniae Carbapenemase (KPC-2) in South Africa. Journal of Clinical Microbiology, 50, 525-527. http://dx.doi.org/10.1128/JCM.05956-11
[22]
Brink, A.J., Coetzee, J., Corcoran, C., Clay, C.G., Hari-Makkan, D., Jacobson, R.K., et al. (2013) Emergence of OXA-48 and OXA-181 Carbapenemases among Enterobacteriaceae in South Africa and Evidence of in Vivo Selection of Colistin Resistance as a Consequence of Selective Decontamination of the Gastrointestinal Tract. Journal of Clinical Microbiology, 51, 369-372. http://dx.doi.org/10.1128/JCM.02234-12
[23]
Peirano, G., Moolman, J., Pitondo-Silva, A. and Pitout, J.D.D. (2012) The Characteristics of VIM-1-Producing Klebsiella pneumoniae from South Africa. Scandinavian Journal of Infectious Diseases, 44, 74-78. http://dx.doi.org/10.3109/00365548.2011.614276
[24]
CLSI (2013) Clinical and Laboratory Standards Institute (CLSI) Guidelines—Performance Standards for Antimicrobial Susceptibility Testing. CLSI Document M100.
[25]
Mendes, R.E., Kiyota, K.A., Monteiro, J., Castanheira, M., Andrade, S.S., Gales, A.C., Pignatari, A.C.C. and Tufik, S. (2007) Rapid Detection and Identification of Metallo-Beta-Lactamase-Encoding Genes by Multiplex Real-Time PCR Assay and Melt Curve Analysis. Journal of Clinical Microbiology, 45, 544-547. http://dx.doi.org/10.1128/JCM.01728-06
[26]
Queenan, A.M. and Bush, K. (2007) Carbapenemases: The Versatile Beta-Lactamases. Clinical Microbiology Reviews, 20, 440-458. http://dx.doi.org/10.1128/CMR.00001-07
[27]
Miyoshi-Akiyama, T., Hayakawa, K., Ohmagari, N., Shimojima, M. and Kirikae, T. (2013) Multilocus Sequence Typing (MLST) for Characterization of Enterobacter cloacae. PLoS ONE, 8, e66358. http://dx.doi.org/10.1371/journal.pone.0066358
[28]
Tenover, F.C., Arbeit, R.D., Goering, R.V., Mickelsen, P.A., Murray, B.E., Persing, D.H. and Swaminathan, B. (1995) Interpreting Chromosomal DNA Restriction Patterns Produced by Pulsed-Field Gel Electrophoresis: Criteria for Bacterial Strain Typing. Journal of Clinical Microbiology, 33, 2233-2239.
[29]
Shet, V., Gouliouris, T., Brown, N.M., Turton, J.F., Zhang, J. and Woodford, N. (2011) IMP Metallo-β-Lactamase-Producing Clinical Isolates of Enterobacter cloacae in the UK. Journal of Antimicrobial Chemotherapy, 66, 1408-1409. http://dx.doi.org/10.1093/jac/dkr078
